Drugs / Merional
Merional
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy4 trials | ||||||
| Phase 1/2 | NCT00823004 Comparator | Jun 2008 → Feb 2009 | ovarian hyperstimulation syndrome | Yazd Research & Clinical Center for Infertility | Completed | No outcome recorded |
| Phase 3 | NCT02470169 Comparator | Jun 2015 → Jun 2017 | infertility disorder | Cairo University | Unknown | No outcome recorded |
| Phase 3 | NCT02469805 Comparator | Jun 2015 → Jun 2018 | infertility disorder | Cairo University | Unknown | No outcome recorded |
| Phase 3 | NCT02461173 Comparator | Jun 2015 → May 2017 | infertility disorder | Cairo University | Unknown | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Merional | “hMG (Merional, IBSA, Lugano, Switzerland)” NCT00823004 ↗ |
| Known as | hMG | “daily intramuscular 150 IU of human menopausal gonadotropins (hMG, Merional ®, IBSA, Lugano, Switzerland)” NCT02469805 ↗2“human menopausal gonadotropins (hMG, Merional ®, IBSA, Lugano, Switzerland)” NCT02470169 ↗ “human menopausal gonadotropins (hMG, Merional ®, IBSA, Lugano, Switzerland)” NCT02461173 ↗ |
| Known as | human menopausal gonadotropins | “daily intramuscular 150 IU of human menopausal gonadotropins (hMG, Merional ®, IBSA, Lugano, Switzerland)” NCT02469805 ↗1“human menopausal gonadotropins (hMG, Merional ®, IBSA, Lugano, Switzerland)” NCT02470169 ↗ |
| Modality | Protein / enzyme biologic | “human menopausal gonadotropins” NCT02469805 ↗ |
| Route | Intramuscular | “receive daily intramuscular 150 IU of human menopausal gonadotropins” NCT02461173 ↗ |